Cervical Disease
Cervical Disease - most related articles:
-
Gardasil vaccine to prevent cervical cancer in India - 5.5
-
IUDs may lower cervical cancer risk - 5.4
-
Early cervical cancer screening may harm women - 5.3
-
Regular pap tests boost chances of cure from cervical cancer - 5.3
-
Cervical cancer screening to 50000 women in India - 5.2
-
HPV DNA testing for all women aged 29 years and above - 4.9
-
TV ad to educate women about cervical cancer and HPV test - 4.8
-
Persistent HPV infection raises cervical cancer risk - 4.8
-
HPV vaccine Cervarix in UK's immunisation programme - 4.5
-
Cervical cancer screening should be less frequent - 4.4
Cervical Disease articles
HPV vaccine reduces subsequent cervical disease in womenHPV vaccination does not reduce progression to cervical disease in women, but vaccinated women had less frequent subsequent cervical disease. Women who are diagnosed with pre-cancerous cervical conditions after receiving the HPV vaccine can still benefit from a considerably reduced risk of reoccurring disease.
Breast cancer and cervical cancer rising in developing countriesThe number of cases and deaths from breast and cervical cancer are rising in most countries, especially in the developing world where more women are dying at younger ages, according to a new global analysis by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.
Gardasil is eligible for UN immunization programsGARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification. GARDASIL is the first cervical cancer vaccine to receive WHO pre-qualification.
Gardasil HPV vaccine prevented genital lesions in menGARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to 26.
QIAGEN's careHPV test provides more accurate screeningA new HPV test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries.
Persistent HPV infection raises cervical cancer riskPersistent infection with human papillomavirus (HPV) could be a useful clinical marker for increased risk of cervical cancer, the second most common cancer in women worldwide, revealed by researchers from the University of North Carolina at Chapel Hill.
Gardasil HPV vaccine reduces abnormal pap test resultsA significant drop in abnormal Pap test results happened after girls and women were given Gardasil vaccine to prevent cervical cancer, according to a researcher at the University of Alabama at Birmingham (UAB).
Quit Smoking – a Healthy Start to 2008The Australian Medical Association AMA is urging all smokers to put their health first in 2008 by making a New Year's resolution to quit smoking for good.
8 Cervical Disease articles listed above.
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.